New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Lantheus said that the FDA approved its PYLARIFY TruVu injection.

Eric Forrest, best known for his time with Voivod and his ongoing work fronting E-Force, has gone public with his battle against prostate cancer. Earlier today, the Toulouse, France–based vocalist and ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

A surgeon in London has carried out what is being described as the United Kingdom’s first long-distance robotic operation on a patient located ...

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...

Penis Botox isn't all that uncommon these days and is chosen for a range of reasons. Tech entrepreneur Bryan Johnson revealed ...

And it costs all of us ...